Effects of histamine on Th1/Th2 cytokine balance.
- K. PackardManzoor M. Khan
- 1 July 2003
Biology, Medicine
New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome
- E. DavisK. PackardJ. KnezevichJennifer A. Campbell
- 1 October 2011
Medicine
Clinicians must have an understanding of the new anticoagulants under development to aid in the selection of appropriate therapies for patients, as new antithrombotic agents under development are highly selective for specific coagulation factors blocking the synthesis of thrombin.
Treatment of Depression in Patients with Concomitant Cardiac Disease.
- Robyn M TeplyK. PackardN. WhiteD. HillemanJ. DiNicolantonio
- 1 March 2016
Medicine
Antipsychotic Use and the Risk of Rhabdomyolysis
- K. PackardP. PriceAshley Hanson
- 15 January 2014
Medicine
Antipsychotic use is a risk factor for rhabdomyolysis and seems to be more common in those taking multiple agents, and more research needs to be done to determine which antipsychotics have a higher risk and which receptors are involved.
A novel cardiovascular risk screening and health promotion service learning course
- K. PackardEmily L SexsonM. SpanglerR. Walters
- 1 October 2010
Medicine, Education
Pharmacologic Prophylaxis of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Beyond β‐Blockers
- E. DavisK. PackardD. Hilleman
- 1 July 2010
Medicine
It is found that sufficient evidence exists to recommend the use of amiodarone, sotalol, and possibly magnesium as monotherapy in patients unable to take β‐blockers or as add‐on therapy for the prevention of POAF.
ACE Inhibitor—Induced Bronchial Reactivity in Patients with Respiratory Dysfunction
- K. PackardR. WurdemanA. Arouni
- 1 June 2002
Medicine
The literature shows that patients with primary airway disease such as asthma and COPD are not at an increased risk of developing cough or bronchoconstriction as a result of ACE-inhibitor therapy, despite the ability of ACE inhibitors to improve exercise tolerance, perfusion, and gas transfer.
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.
- K. PackardD. Hilleman
- 1 December 2016
Medicine
Nonadherence to CVD-preventative medications such as aspirin remains a substantial area of unmet need and represents a key opportunity for the development of quality-of-care enhancement programs to improve health outcomes in this patient population.
Prophylactic acetylcysteine is not effective in preventing contrast-induced nephropathy following coronary angiography
- J. B. OldermeyerErica CichowskiR. WurdemanK. PackardW. BiddleA. Mooss
- 1 March 2003
Medicine
Pharmacist's role in an interdisciplinary cardiac rehabilitation team.
- K. PackardM. HerinkP. Kuhlman
- 2012
Medicine
Pharmacists can play a vital role as part of an interdisciplinary cardiac rehabilitation team to ensure proper adherence to cardiac medications and patient safety through patient education and interventions.
...
...